Posted inNews and Updates
FDA Approves Tudriqev for Advanced Melanoma Treatment
The FDA has approved Tudriqev for advanced melanoma, offering a new treatment pathway for patients who have developed resistance to anti-PD-1 therapies.
Posted inNews and Updates
Heart Drug Trial Fails: New Anti-Inflammatory Setback
A promising new heart drug targeting inflammation has failed its latest clinical trial, missing key efficacy endpoints for preventing heart attacks.
Posted inNews and Updates
AI Remains Underutilized in Clinical Trial Operations
Clinical trials are falling behind in AI adoption. Discover why industry leaders say underutilization of technology is stalling medical innovation.
Posted inNews and Updates
New BathMat Tool Improves ICU Patient Care and Efficiency
The BathMat sensor technology is revolutionizing ICU care by reducing nursing workloads and improving patient monitoring for better clinical outcomes.
Posted inNews and Updates
Dronabinol and PTSD: Lessons for CNS Clinical Trials
New trial data on Dronabinol for PTSD highlights critical gaps in CNS clinical trial design. Learn why trial methodology is failing to capture efficacy.
Posted inNews and Updates
Tenaya TN-201 Gene Therapy Shows Promise in HCM Trial
Tenaya's TN-201 gene therapy shows breakthrough results in reducing heart muscle thickness for HCM patients. Discover the latest clinical trial data.
Posted inNews and Updates
Kymera Ends KT-621 Trial Early: Atopic Dermatitis Update
Kymera Therapeutics completes enrollment for its KT-621 trial six months early, marking a major milestone in developing new treatments for atopic dermatitis.
Posted inNews and Updates
New Rebecsinib Clinical Trial Offers Hope for Blood Cancer
A new clinical trial for rebecsinib offers a breakthrough approach to treating aggressive blood cancers like AML and MDS. Learn about this targeted therapy.
Posted inNews and Updates
Safety Concerns Mount After Child Death in Gene-Editing Trial
A tragic pediatric death in a Chinese gene-editing trial has reignited global concerns over safety, ethics, and the need for greater clinical transparency.
Posted inNews and Updates
New Clinical Trial Framework Set to Fight CMT Disease
A new standardized clinical trial framework for Charcot-Marie-Tooth disease aims to speed up drug development and improve treatment outcomes for patients.